|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's range||370.95 - 387.90|
|52-week range||318.50 - 695.18|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||50.56|
|Earnings date||31 Oct 2022 - 04 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||491.71|
Designed to thrive in challenging economic conditions, these companies are great buys during a downturn.
Every investor in IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) should be aware of the most powerful shareholder groups...
Participating in the call this morning are Jay Mazelsky, president and chief executive officer; Brian McKeon, chief financial officer; and John Ravis, vice president, investor relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements.